Skip to main content

JPMORGAN CHASE & CO

Position in REPL — Replimune Group, Inc.

CIK 19617 NEW YORK, NY

Position in REPL

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$6,043,123
-$2,949,557 QoQ
Shares Held
789,951
-14.6% QoQ
Ownership
0.941%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 85% Shared 0% None 15%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. REPL ranks #91 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in REPL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,043,123 789,951
2025-12-31 $8,992,680 925,173
2025-09-30 $159,286 38,016
2025-06-30 $337,263 36,304
2025-03-31 $2,150,722 220,587
2024-12-31 $5,892,833 486,609
2024-09-30 $2,732,864 249,349
2024-06-30 $2,171,475 241,275
2024-03-31 $2,223,325 272,133
2023-12-31 $2,571,343 305,023
2023-09-30 $6,545,172 382,535
2023-06-30 $7,033,778 302,919
2023-03-31 $2,882,288 163,210
2022-12-31 $4,153,222 152,692
2022-09-30 $2,847,321 164,871
2022-06-30 $519,119 29,698
2022-03-31 $338,885 19,958
2021-12-31 $10,343,418 381,676
2021-09-30 $12,091,073 407,931
2021-06-30 $13,441,312 349,852
2021-03-31 $9,833,524 322,305
2020-12-31 $7,614,929 199,605
2020-09-30 $818,544 35,558
2020-06-30 $144,725 5,824
2020-03-31 $41,654 4,178